Obesity and outcomes following burns in the pediatric population

Evan Ross1, Agnes Burris1, Joseph T Murphy1

  • 1Pediatric Surgery, Children's Medical Center Dallas, Dallas, TX USA; Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX 75235, USA.

Insights

Obese children with burns require more intensive medical care, including longer mechanical ventilation and BICU stays, but do not have higher mortality rates. This suggests obesity increases morbidity in pediatric burn patients.

Area of Science:

  • Pediatric burn care
  • Obesity in children
  • Medical outcomes research

Background:

  • Obesity is linked to worse outcomes in adult burn patients.
  • The impact of obesity on pediatric burn outcomes is not well understood.

Purpose of the Study:

  • To investigate the association between obesity and outcomes in pediatric burn patients.
  • To compare outcomes between obese and non-obese children with thermal injuries.

Main Methods:

  • Retrospective analysis of thermal injury data from 536 pediatric patients (≤18 years).
  • Obesity defined by WHO or CDC growth charts (≥95th percentile).
  • Outcomes compared between obese (n=154) and non-obese (n=382) children.

Main Results:

  • Obese and non-obese children had similar TBSA, full-thickness burn percentages, and mortality rates.
  • Obese children required significantly more days of mechanical ventilation (4.89 vs. 2.67 days).
  • In a subgroup without inhalation injury, obese children had longer ICU LOS (18.59 vs. 9.51 days) and mechanical ventilation days (11.65 vs. 3.92 days).

Conclusions:

  • Obese pediatric burn patients require more intensive medical support, including respiratory intervention and BICU care.
  • Unlike adult findings, obesity was not associated with increased mortality in this pediatric cohort.
  • Obesity appears to be a risk factor for increased morbidity in pediatric burn patients.
Abstract

Related Concept Videos

Burn Injuries01:22

Burn Injuries

Burn injuries occur when the skin and underlying tissues are damaged due to exposure to heat, electricity, chemicals, radiation, or friction. They can vary in severity, from minor superficial burns to severe deep burns that can be life-threatening.
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
4.4K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
440
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
368
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
324
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967